4Suppliers
7Customers
2Debt Items
20Related Chains

Compugen Ltd. Suppliers

TickerNameConfidenceEvidence
GRAN Grande Group Limited 85% Reciprocal relationship from GRAN graph: nformation Our principal executive offices are located at Suite 2701, 27/F, Tower 1, Admiralty Center, 18 Harcourt Road, Admiralty, Hong Kong. Our registered …
SNTG Sentage Holdings Inc. 85% Reciprocal relationship from SNTG graph: ce in the Cayman Islands is located at Ogier Global (Cayman) Limited 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands, and the phone number of …
SNYNF Sanofi 72% d be leaked or disclosed to others, including if sensitive information is used to train third party AI/ML. Where an AI/ML model ingests sensitive information and makes connections using such data, th…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from CGEN graph: d be leaked or disclosed to other…

Compugen Ltd. Customers

TickerNameConfidenceEvidence
AZN AstraZeneca PLC 92% Reciprocal relationship from AZN graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from AZN graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from AZN grap…
AZN AstraZeneca PLC 92% Under the terms of the license agreement, as amended (including most recently as December 16, 2025), we provided an exclusive license to AstraZeneca to use our monospecific antibodies that bind to TI…
GILEAD GILEAD 92% Under the terms of the license agreement, we granted Gilead an exclusive license under our preclinical antibody program against IL-18 binding protein and all intellectual property rights subsisting t…
GILD Gilead Sciences, Inc. 85% below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. F - 2 Kost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A, Tel-Avi…
GILD Gilead Sciences, Inc. 85% Reciprocal relationship from GILD graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from GILD graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from GILD g…
SNYNF Sanofi 72% res designed to protect against security breaches and other incidents and maintain offsite back-ups of our data, such measures may fail. We maintain periodic security patches and upgrades of third-pa…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from CGEN graph: res designed to protect against s…

Compugen Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CGEN-DEBT-8612 Warrants outstanding: 89557 90% xbrl warrant detail from xbrl 2023-12-31.
CGEN-DEBT Debt stack $3.0M 90% Market cache reports total debt of $3.0M.

Compugen Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Compugen Ltd..

Compugen Ltd. Ownership

HolderNameConfidenceEvidence
CGEN-OWNER-SILVERARC-CAPITAL-MANAGEMENT-LLC SILVERARC CAPITAL MANAGEMENT, LLC 90% 13F overlay lists SILVERARC CAPITAL MANAGEMENT, LLC as top holder; 79 tracked holders.

Compugen Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CBIO Crescent Biopharma, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
AVIR Atea Pharmaceuticals, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 1 ['receiving']
ANRO Alto Neuroscience, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
DEO Diageo plc 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2